BEAM/ 09/03/2025 · 1:24 PM Beam Therapeutics' Edge Against Wave's Trial Data Beam Therapeutics rallied after Wave Life Sciences' WVE-006 trial data for alpha-1 antitrypsin deficiency (AATD) fell below expectations.
